WELL Health Technologies (TSE:WELL) Issues Quarterly Earnings Results

by · The Cerbat Gem

WELL Health Technologies (TSE:WELL – Get Free Report) posted its earnings results on Thursday. The company reported C$0.06 earnings per share (EPS) for the quarter, FiscalAI reports. WELL Health Technologies had a negative return on equity of 0.87% and a negative net margin of 0.53%.The firm had revenue of C$368.26 million during the quarter.

Here are the key takeaways from WELL Health Technologies’ conference call:

  • Q1 results were strong with revenue of CAD 368.3M (+25% YoY), Adjusted EBITDA of CAD 43.1M (+56%), and adjusted net income of CAD 15.5M (doubled YoY), signaling robust core performance.
  • Canadian clinics momentum — the network grew to 253 clinics with 1.3M Canadian patient visits (+31% YoY), is on track to exceed CAD 500M in clinics revenue in 2026, and is targeting ~CAD 800M revenue and >CAD 100M Adjusted EBITDA run-rate within the next 12 months, supported by a CAD 400M senior credit facility and a ~CAD 260M pipeline under LOI.
  • Regulatory and procurement tailwinds — federal Bill S‑5 and Ontario’s province‑wide EMR initiative favor interoperable, sovereign Canadian platforms, positioning WELL’s integrated stack (WELLSTAR, HEALWELL AI, CYBERWELL plus clinics) to compete for large public procurements.
  • WHIP, AI and investment phase — WELL is building the WELL Health Intelligence Platform (WHIP) and consolidating CYBERWELL/WELL Research to drive AI‑led efficiency and a back‑half 2026 cost‑optimization program, but Q1 capex rose 88% and adjusted free cash flow fell to CAD 1.6M due to these investments.
  • U.S. strategic review and Circle Medical updates — WELL is pursuing strategic alternatives for U.S. assets (WISP, Circle Medical, CRH); Circle recognized ~CAD 12.8M of deferred revenue in Q1, expects minimal remaining deferrals in Q2, and reports a deal‑in‑principle with U.S. regulators, but final outcomes and timing remain uncertain.

WELL Health Technologies Stock Down 5.0%

TSE:WELL opened at C$4.15 on Friday. WELL Health Technologies has a 1 year low of C$3.58 and a 1 year high of C$6.08. The company has a current ratio of 1.03, a quick ratio of 1.02 and a debt-to-equity ratio of 82.33. The stock has a market cap of C$1.06 billion, a price-to-earnings ratio of -138.33, a PEG ratio of -1.93 and a beta of 0.93. The stock has a 50-day moving average price of C$4.09 and a two-hundred day moving average price of C$4.14.

Wall Street Analyst Weigh In

Separately, Scotiabank decreased their target price on WELL Health Technologies from C$7.00 to C$6.50 and set an “outperform” rating for the company in a research note on Wednesday, February 4th. Two investment analysts have rated the stock with a Buy rating, According to MarketBeat, the stock has an average rating of “Buy” and an average target price of C$6.25.

Get Our Latest Report on WELL Health Technologies

WELL Health Technologies Company Profile

(Get Free Report)

WELL Health Technologies Corp is the owner and operator of a portfolio of Primary Hclinics delivering healthcare-related services It operates through below segments: clinical operations and allied health, Electronic medical record (EMR), Billing and revenue cycle management solutions, Digital apps, Cybersecurity, CRH, MyHealth, and corporate/shared services. Its segments are grouped in three divisions; Omni-channel Patient Services – Primary includes clinical operations and allied health. Omni-channel Patient Services – Specialized comprises CRH and MyHealth under two segments.

Recommended Stories